Stanley R. Frankel's most recent trade in Precision Biosciences Inc was a trade of 2,700 Common Stock done at an average price of $4.7 . Disclosure was reported to the exchange on Dec. 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Precision Biosciences Inc | Stanley R. Frankel | Director | Purchase of securities on an exchange or from another person at price $ 4.70 per share. | 16 Dec 2025 | 2,700 | 19,478 (0%) | 0% | 4.7 | 12,690 | Common Stock |
| Precision Biosciences Inc | Stanley R. Frankel | Director | Purchase of securities on an exchange or from another person at price $ 4.97 per share. | 26 Sep 2025 | 2,700 | 16,778 (0%) | 0% | 5.0 | 13,419 | Common Stock |
| Precision Biosciences Inc | Stanley R. Frankel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 21,000 | 21,000 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Stanley R. Frankel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2025 | 9,826 | 0 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Stanley R. Frankel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 May 2025 | 9,826 | 14,078 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Stanley R. Frankel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 9,826 | 9,826 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Stanley R. Frankel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 4,202 | 0 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Stanley R. Frankel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 4,202 | 4,252 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | Stanley R. Frankel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 126,075 | 126,075 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Stanley R. Frankel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 156,951 | 156,951 | - | - | Stock Option (Right to Buy) | |
| Precision Biosciences Inc | Stanley R. Frankel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2021 | 63,325 | 63,325 | - | - | Stock Option (Right to Buy) |